UnitedHealth CEO Addresses Systemic Issues Following Executive's Murder

Andrew Witty highlights high drug prices and system inefficiencies while defending the company’s role in healthcare reform.

UnitedHealth CEO Andrew Witty made his first public remarks since the December 2024 murder of UnitedHealthcare CEO Brian Thompson, expressing condolences and reflecting on healthcare system challenges.
Witty attributed high healthcare costs in the U.S. to inflated prices for procedures, visits, and prescriptions, particularly citing GLP-1 drug prices as an example of disparities with other countries.
UnitedHealth reported $14.4 billion in 2024 profits despite a cyberattack and a significant $63 billion loss in market value following Thompson's death.
The company plans to pass 100% of drug rebates to consumers and employers by 2028, aiming to increase transparency and reduce drug prices.
The murder of Thompson has intensified scrutiny of the healthcare system, with public sentiment showing distrust toward insurers and a federal investigation underway into the accused shooter’s motives.